Cellular and molecular mechanisms of the immunomodulatory action of glycyrrhizin (GL) were studied. We demonstrated that GL displays a unique action to prolong the duration of the T-cell receptor-mediated in vitro splenic T-lymphocyte growth response to anti-CD3 monoclonal antibody (mAb) or concanavalin A (Con A) through enhancement of interleukin-2 (IL-2) secretion and IL-2 receptor (IL-2R) expression. The augmentation by GL of IL-2 production was also found in spleen cells stimulated with A23187 plus phorbol 12-myristate 13-acetate (PMA), suggesting that GL primarily affects some post-receptor stage of the signal transduction. We also found that the time of GL action for promoting IL-2 production and growth response was 2 hr or more after receptor activation. Correspondingly, GL did not augment the anti-CD3 mAb or Con A-mediated protein tyrosine phosphorylation and c-fos transcription. We concluded from these results that GL acts as a promoter of the late signal transduction of T lymphocytes for IL-2 production.
更多
- Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C
- APASL2006中文版
- PROSPECTIVE ASSESSMENT OF THE INCIDENCE OF INFECTIONS DURING PEGYLATED INTERFERO
- A Long-Term Glycyrrhizin Injection Therapy Reduces Hepatocellular Carcinogenesis
- Glycyrrhizin in Chronic Hepatitis C Patients
- Therapeutic effects of stronger neo-minophagen C at different doses on chronic
- Therapeutic effects of Stronger Neo-Minophagen C (SNMC) in patients with chronic
- Randomized clinical trial with SNMC in Chin-BE Wang-ok
- The long term efficacy of glycyrrhizin in chronic hepatitis C patients
- Hepatitis C viral infection